Renaissance Technologies LLC Purchases 294,327 Shares of Omega Healthcare Investors, Inc. $OHI

Renaissance Technologies LLC lifted its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 88.9% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 625,378 shares of the real estate investment trust’s stock after acquiring an additional 294,327 shares during the quarter. Renaissance Technologies LLC’s holdings in Omega Healthcare Investors were worth $27,404,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the company. State Street Corp raised its stake in Omega Healthcare Investors by 4.8% in the 2nd quarter. State Street Corp now owns 14,591,873 shares of the real estate investment trust’s stock valued at $534,792,000 after acquiring an additional 671,473 shares during the period. Geode Capital Management LLC boosted its position in Omega Healthcare Investors by 9.4% during the fourth quarter. Geode Capital Management LLC now owns 8,515,924 shares of the real estate investment trust’s stock worth $377,648,000 after purchasing an additional 734,774 shares during the period. Invesco Ltd. increased its stake in shares of Omega Healthcare Investors by 8.6% in the fourth quarter. Invesco Ltd. now owns 5,368,945 shares of the real estate investment trust’s stock worth $238,059,000 after purchasing an additional 424,024 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Omega Healthcare Investors by 4.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,463,838 shares of the real estate investment trust’s stock valued at $197,927,000 after purchasing an additional 174,062 shares during the period. Finally, Bank of New York Mellon Corp raised its position in shares of Omega Healthcare Investors by 18.5% in the fourth quarter. Bank of New York Mellon Corp now owns 4,457,975 shares of the real estate investment trust’s stock valued at $197,667,000 after purchasing an additional 696,759 shares during the period. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors News Roundup

Here are the key news stories impacting Omega Healthcare Investors this week:

• Positive Sentiment: FFO and revenue exceeded expectations. Second-quarter funds from operations (FFO) came in at $0.83 per share, up from $0.77 a year earlier and above the $0.80 consensus estimate. Revenue rose 16.2% year over year to $328.25 million, surpassing analysts’ $266.97 million forecast. Omega Healthcare Investors Q2 FFO and Revenues Beat Estimates
• Positive Sentiment: Full-year guidance was raised or reaffirmed above consensus. OHI provided fiscal 2026 EPS guidance of $3.22 to $3.26, compared with the analyst consensus of approximately $3.10. This suggests management expects continued operating momentum and supports the earnings outlook. Omega Reports Second Quarter 2026 Results and Recent Developments
• Positive Sentiment: Accretive investment activity contributed to the results. Reports attributed the earnings beat partly to investments expected to generate attractive returns, potentially supporting future revenue and FFO growth. Omega Healthcare Investors Q2 earnings top consensus on accretive investment activity
• Neutral Sentiment: OHI shares have been trading close to their 52-week high, with momentum supported by results but valuation and profit-taking potentially limiting near-term upside. The stock’s relatively low beta may also reduce sensitivity to broader market swings.

Analysts Set New Price Targets

Several research analysts recently commented on OHI shares. Weiss Ratings raised shares of Omega Healthcare Investors from a “buy (b)” rating to a “buy (b+)” rating in a report on Tuesday, June 30th. BMO Capital Markets restated a “market perform” rating and set a $52.00 target price on shares of Omega Healthcare Investors in a research report on Monday, May 4th. Citigroup reaffirmed a “market perform” rating on shares of Omega Healthcare Investors in a report on Monday, June 15th. Barclays initiated coverage on Omega Healthcare Investors in a research report on Tuesday, July 7th. They issued an “underweight” rating and a $51.00 price target for the company. Finally, Wells Fargo & Company boosted their price objective on Omega Healthcare Investors from $47.00 to $49.00 and gave the company an “equal weight” rating in a research note on Monday, June 1st. Five research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $48.50.

Omega Healthcare Investors Stock Performance

Omega Healthcare Investors stock opened at $51.32 on Thursday. The firm’s fifty day moving average price is $47.65 and its 200-day moving average price is $46.59. The company has a debt-to-equity ratio of 0.81, a quick ratio of 5.32 and a current ratio of 5.32. The stock has a market cap of $15.28 billion, a P/E ratio of 24.79, a price-to-earnings-growth ratio of 2.20 and a beta of 0.58. Omega Healthcare Investors, Inc. has a fifty-two week low of $38.59 and a fifty-two week high of $52.07.

Omega Healthcare Investors (NYSE:OHI) last announced its earnings results on Tuesday, April 28th. The real estate investment trust reported $0.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.49 by ($0.02). The company had revenue of $322.95 million during the quarter, compared to analysts’ expectations of $264.07 million. Omega Healthcare Investors had a return on equity of 11.86% and a net margin of 51.14%.The firm’s revenue was up 16.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.75 earnings per share. On average, equities research analysts expect that Omega Healthcare Investors, Inc. will post 3.09 earnings per share for the current fiscal year.

Omega Healthcare Investors Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Monday, August 3rd will be paid a dividend of $0.68 per share. This represents a $2.72 annualized dividend and a yield of 5.3%. This is an increase from Omega Healthcare Investors’s previous quarterly dividend of $0.67. The ex-dividend date of this dividend is Monday, August 3rd. Omega Healthcare Investors’s dividend payout ratio is presently 129.47%.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.